The present study findings suggest there should be further investigation into the potential role of decreased amplitude of BOLD-LFOs in APOE4-related AD pathophysiological changes with potential implications for our understanding of early-stage AD and related diagnostic approaches. Here, APOE is linked to Alzheimer disease.